@NPRA1985 https://www.globaltimes.cn/content/1210051.shtml

I think it's coming soon.

Selling off and moving on. For those still hopeful, continue to hope. In a year it should cross all barriers with a few limit-ups even. Heck, there may even be a bonus or two coming, who knows. Bamboos will flower if you wait long enough.

Nothing strange - if only people buy after looking at all the quarter results from early this year. But lots of buyers are hoping for limit-ups. So we see a huge price fluctuations - punters who throw so that they have enough liquidity to move to other counters they think will have a limit-up. If one understands the harddisk business, then there is no worry. RM1.35 is a bit far a target, but easily it should be revalued at 0.85-0.95

Yes, LKL's worth is about 90+ if you consider the gloves business bonus. But people are so panicky these days they didnt realise that current price is before it announced getting gloves contract. The loss in quarter profit is also the regular trend if you look at LKL's past results. So, at 80+ sen, those who know, knows that it is bargain price in your favour

@nighthunter
Poor quarter results. They sold yesterday, you sell today, they pick up again cheap. Very smart move

Look, we know that the sinopharm vaccine is both effective and halal. UAE gave its endorsement. Indonesia probably too since it takes its cue from the halal big brother in UAE. Now, we need to know how exclusive is Kanger's distributorship. is it the sole distributor or one of the few selected ones by Sinopharm. Next, we need to find out - if there are a few distributors in Malaysia - if Kanger has a substantial clientele, ie private hospitals and if Government hospitals are using the Verocell it is distributing. Once you have this, you can roughly estimate Kanger's profitability for the next 24 months,

@NPRA1985 10% - Covax

Malaysia strives to acquire herd immunity when 70% of the population is innoculated, I believe. If you take the population as 35mil, It will need to vaccinate about 25mil people. That is the number of doses (x2) that the country will need, assuming it goes for the Pfizer model. I doubt Pfizer can supply all that. So, it will be also through Covax. Now, if you can roughly estimate how much Pfizer and Covax can supply, then the figure left will be that from China's Sinopharm. Now, this is by no mean conclusive estimate of how much of the vaccine will be distributed by Kanger. As I said earlier, its investor relations team sucks big time.

If my guess is right, this is as low as it gets. If it breaches the 200MA, then it will close at 0.14 - which is bad for the party to which it placed its shares privately.

MoU is not binding.

@2323 if kanger good news announce early ,company need push down price for pp...so there won't announced anny good news b4 pp...pp today complete, kanger good news coming soon

Not logical. If you have a share price driven by good news, say twice the PP, then the PP recipient will be more than happy to accept because of the instant profitability. Isnt it?


What I suspect is happening is the company directors are mopping up at 0.17 so that market price will not be lower than PP. If it is, then why should companies invest in the PP, might as well pick cheap from the market

Fair price is 0.16 I think. That's why you see no one wants to buy 0.17 even. Real investors wont let this go by if there is a gain to be made - even if there is a certain length of waiting time. Unless you see a spurt in price, there is not much purpose singing praises

Results coming in roughly 9 days. Keeping fingers crossed. From past records, it may be even better.

@NPRA, yes, have seen this earlier but good job sharing it with others. That was why I said the Kanger investor-relations fellas are not doing a good job. If investors need to hunt and seek for infos as basic as those in their fingertips, it means they dont respect funds keeping their salaries alive.

I think lots of speculators who missed the vaccine boat bought in heaps of Kanger in the hope that making that kill, not knowing head or tail but depended on the rumours filled by other speculators who moved in much earlier. In a dog eat dog world, those caught at the most unfortunate end live on that last shred of hope - and when others point out what is at stake, verbal fights take place. The trick to investment is to do research properly. Then you dont have to worry about bad news purportedly created by others because you already know what you are in. It's like buying your first house - or car - you check and check until you are happy. If you dont, you have only yourself to curse if you bought a lemon instead of a tangerine

Yes, NPRA. we have to wait for a lot of things - one closest at hand is for Kangar to have some investor-responsibility. In matters of this nature, at least their investor-relations department should be informing investors and potential ones what is on the line and what is coming in next hour. Sitting down and watching the fun, reading good and bad news on all forums is irresponsible. Definitely not for good corporate governance. And this reflects lots on a company in general

They are involved. Even the endorsement was given in National TV by the MoH. But big investors know something speculators may not, so, the truth is still out there. Unimaginably, there is no communication updates from the company on its role on this, nor how far the purported vaccine it is to distribute is effective and much sought after

Has Sinopharm released any irrefutable data? So far I have not see any. This morning, FDA just released statement that the Pfizer vaccine being rolled out in UK is surprisingly more effective than earlier presumed. CNN caught the newsbreak moments ago. Until Sinopharm relieves all doubts on its vaccine, and any substantial information subsequent, it is going to be eclipsed by other news on Western vaccines. Even the UAE declaration is ineffective against what is popping up for Pfizer. As for Kanger, it is better to just focus on its bamboo business. Vaccine distribution could at best be a profitable side business, if at all it is.

Today Kanger ends its drop. With MACD crossovers, you could be looking at prices between 0.18 and 0.205. For the past three days, there have been spurts of rises only to be dragged down by selling. I believe this trend has just ended around 4pm today with a MACD crossing its signal line at a point where retailers have met their match in smartmoney volume. Time to monitor your investments from this point onwards

A captive market with the econfirm. What else need be said? It's last high was 0.92. It may retrace back to higher highs

Health budget allocation will benefit this counter. After Covid, private and public hospitals will be forced to refurbish because the stigma related to beds and equipment used for Covid red zones in hospitals. Word will travel fast and furious which hospital has "cleaned up" their rooms with new beds, replacing those used for Covid wards. Then you will see orders come in to LKL.

Kanger appointed K-star. So, if Kanger is non-performing, it will be quite silly to hope K-star will fly

and so it will close another day at 0.175 and start all over again next week.

If staff sell ESOS stocks it means 1) they damn poor because pay not enough 2) they dont trust company any more, get money and run

dont waste time - just leave it be. If vaccine comes, it will go up another 10 sen or so. This is not a vaccine maker. Only a distributor channel. Middle man. Doesnt make sense that it will go up like Bintai or HWGB.

wait at 0.785

Still hopeful on a practically predictably hopeless company

Track Sinovac on Nasdaq - that will tell you if you can sleep better or not If it goes up suddenly, vaccine is coming. Is it continues to trade sideways like Kanger, dont waste your time. Being hopeful is good. Losing sleep being too hopeful is silly.

Read here about Verocell - the one Malaysia is purportedly getting

https://www.abc.net.au/news/2020-11-07/chinese-coronavirus-trial-vaccine-phase-3-covid-19/12851880

Reason Bintai is flying is that it is directly involved with a vaccine-maker - nevermind if the maker doesnt have anything to show or the stocks have being trashed. The gambler mentality supercedes all. That is how herd mentality works.

Pressure now on China with Pfizer's approvals. If Sinopharm dont announce any data about efficacy of its vaccine, it will confirm what the West already been peddling - that China vaccine is not tested for success

@jutawansenyap

Yes, would think 0.16 is a good bet. But chartwise, it may just turn and head towards 0.20. As it is, the sentiment is damp - left hand sell, right hand buy, and repeat

Facts:
No1: US$40m (RM167mil) contract to supply nitrile gloves to Hong Kong-based company this month,
No 2: US$18.96mil (RM78.49mil) contract to supply nitrile gloves to a China-based company in Sept.

As expected, it reached a new high today. The KPJ group can be likened to the convenience store of private hospitals. It has a total of 29 hospitals in the country and interest in Indonesia. Citibank's creditcard even a list of KPJ Hospitals. This tells you how poised it is already as a private medical facility in the country.

How many of private, GLCs, and semi-government agencies are using its services, only a detailed count can reveal. With the coming availability of vaccine, one would expect private hospitals like this one - which has an extensive clientele comprising private companies and semi-government entities (GLCs also) - would be the immediate beneficiary. Ther are well equipped with storage facilities and expertise to meet on-demand needs than public facilities where queues are common and frustrating.

@NPRA1985, by your logic, I've just upped another 100k@0.18. I hope you are on the right path and not going to Holland.

Pharmaniaga already planning how our is going to distribute the vaccine but kanger still has no news. Smelling con job.

Left hand sell, right hand buy. Then reverse. Then start again.

Nah, this is why. Read up and understand what is coming.
https://www.westerndigital.com/products/data-center-drives#hard-disk-hdd

Heard YoY coming in next week or so will be record high. Anyone has any leads? Thanks

Forget it - either keep until it hits a high. technically, it is only a vaccine distributor. it doesn't work with vaccine companies. how much can a distributor make? think of it as Grab Food. It is not the restaurant. It only delivers food. When there is Food Panda, and more, how much can it make?

Kanger will not go up - the trend is left sell, right hand buy. From 17.5 trade to 19.5. then back again. Only thing is volume goes up. Meaning the gullible are being scalped.

Budget approved - this stock should benefit from it.

https://www.theedgemarkets.com/article/technology-players-among-businesses-most-receptive-budget-2021

Luckily I went out earlier than you

not good, from 8mil now 18mil selling at 19.5

no harm hoping - look at the sell numbers. Once it is higher, then decide whether to hold or sell. this AT has been trading funny the last few days.

https://www.scmp.com/news/china/society/article/3111347/coronavirus-sinopharm-applies-regulatory-approval-china-launch

Once permission is given and Sinopharm is allowed to launch, it will be a new ball game. They cant announce any earlier because of this. They did mention that they are producing vaccine for the world, and Malaysia is one of the priority beneficiaries. Kanger will benefit in no small way if Sinopharm vaccine is adopted.

Sold 19.5!

results delayed?

results should be coming in soon. let's see if it is true HDD sales drop

https://www.computerweekly.com/microscope/news/252482331/HDDs-big-comeback

Worth noting, this story. Published in April, but relevance is undeniable.

It will drop again - 0.16 or 0.15 will be good bargain. Dont hold too long, sell if there is profit

https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=0119

what do you mean poor quarter results? 84% is commendable.